ClinicalTrials.govpublic full text
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX
metastatic pancreas cancer, locally advanced pancreatic cancer, pancreatic adenocarcinoma, folfirinox, 5-fluorouracil, folinic acid, irinotecan, oxaliplatin, gemcitabine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 894842
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.